Arkansas Diabetic Medications and Insulin Pump Therapies

$29.00

About the Course


Audience:  This medication rich course is for all nurses and advanced nurse practitioners responsible for prescribing diabetic medications and managing patients with diabetes. 

Course Overview:  Diabetes and glycemic medications are in the news every day.  Staying ahead of current research and treatment options is an uphill challenge.  This course provides the latest in diabetic medications and treatment options, including insulin pump therapies.  

Objectives

  1. Describe the normal processing of blood glucose in a healthy person.
  2. Discuss the altered processing of blood glucose in diabetic patients.
  3. Recognize the effects of sulfonylureas on blood glucose control, cardiovascular effects of sulfonylureas, their adverse reactions, and the currently available sulfonylureas.
  4. Describe the characteristics of meglitinides, including effects on blood glucose control, cardiovascular effects, adverse reactions, and the medications available in this class.
  5. Discuss metformin's effects on blood glucose control, cardiovascular effects, and its potential adverse reactions.
  6. Recognize the characteristics of thiazolidinediones, including effects on blood glucose control, impact on cardiovascular health, and contraindications to the use of this class of medication.
  7. Explain the effects of amylin analogs on blood glucose control, cardiovascular effects, adverse reactions, and their dosing.
  8. Describe the characteristics of alpha glucosidase inhibitors, including effects on blood glucose control, cardiovascular effects, and the dosing and availability of these agents.
  9. Discuss the characteristics of glucagon-like peptide-1 (GLP-1) receptor agonists, including effects on blood glucose control, cardiovascular effects, adverse reactions, and the use of short acting vs. long acting agents.
  10. Explain the characteristics of dipeptidyl peptidase-4 (DPP-4) inhibitors, including effects on blood glucose control, cardiovascular effects, adverse reactions, and the currently available DPP-4 inhibitors.
  11. Identify the characteristics of sodium-glucose cotransporter 2 (SGLT-2) inhibitors, including effects on blood glucose control, common adverse reactions, and the currently available SGLT-2 inhibitors.
  12. Discuss the available insulin products, including the difference between basal and prandial insulin, the insulin products currently available, common types of insulin regimens, the use of insulin pumps.

About the Author

Katie Ingersoll, PharmD, RPh 

Dr. Ingersoll graduated from Northeastern University with a Doctor of Pharmacy degree in 2009. She works for a national chain pharmacy and has a certificate in Pharmacy-Based Immunization Delivery from the American Pharmacists Association. She is actively involved in administering vaccinations and counseling patients about vaccine-related concerns on a daily basis.

  • bvseo_sdk, p_sdk, 3.2.0
  • CLOUD, getContent, 87.19ms
  • REVIEWS, PRODUCT
  • bvseo-msg: HTTP status code of 404 was returned;